One-Stop Resume Posting to Over 75 Career Sites. Click Here

Median Salary by Years Experience – Job: Sales Representative, Pharmaceuticals (United States) CAREER TOOLS: Salary Calculator, Career Path Tool, Cost of Living Calculator, Meeting Miser

E-Mail your Resume and Cover Letter to 1000’s of Headhunters, Click Here




Career Assessment
Get a free career assessment and be recruited by companies in your area.

Pharmaceutical Sales Jobs – Videos About the Resume

The following is a current listing of job openings in the United States for the pharmaceutical sales representative.

Pharmaceutical Sales Jobs – Listed by State – Updated Daily

Most Popular Skills – Job: Sales Representative, Pharmaceuticals (United States) CAREER TOOLS: Salary Calculator, Career Path Tool, Cost of Living Calculator, Meeting Miser

Pharmaceutical Industry News

Pharma Industry / Biotech Industry News From Medical News Today
Copyright 2010 Medical News Today
Latest Health News and Medical News posted throughout the day, every day.

Improving Drug Therapy Using Gene Profiles
The National Institute of General Medical Sciences has awarded a $9.1 million, five-year grant to The Ohio State University for a study titled "Expression Genetics in Drug Therapy." The goal of the research is to enhance drug response rates and reduce the number of adverse drug reactions among patients taking medication...
Abbott Completes Acquisition Of Piramal's Healthcare Solutions Business, Becomes Leading Pharmaceutical Company In India
Abbott has completed its acquisition of Piramal's Healthcare Solutions business, propelling it to market leadership in the Indian pharmaceutical market and further accelerating the company's growth in emerging markets...
Nonprofits Detail Health Industry Ties
The New York Times: A journal that tracks philanthropy and giving has published information about contributions made by medical companies to health-related nonprofits following a request for similar information by a lawmaker...
Digipharm Europe 2010, Europe's Leading Digital Marketing Conference For Senior Pharmaceutical Executives 28th Sept - 1st October
The 2nd annual DigiPharm Europe 2010 will discuss the challenges and strategies used to enhance online communication, customer relationship, strengthen brand awareness and improve profitability in digital marketing. We spoke to some of the speakers recently on Pharma Marketing Live who gave some great feedback on what they intend to present on...
Tragara Pharmaceuticals Initiates Phase I Clinical Program For TG02
Tragara Pharmaceuticals, Inc. announced the initiation of a phase I clinical trial of TG02, a unique oral multi-kinase inhibitor, in patients with advanced/refractory hematologic malignancies. Tragara will conduct the study at multiple clinical centers in the United States...
Cempra Pharmaceuticals Presents New Data On TAKSTA™ (CEM-102, Sodium Fusidate) At The 50th Interscience Conference
Cempra Pharmaceuticals announced abstracts to be presented on its oral anti-MRSA antibiotic, TAKSTA (sodium fusidate, formerly CEM-102), at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 12 to 15, 2010, in Boston. Data to be presented demonstrate that TAKSTA showed clinical success rates and tolerability comparable to oral linezolid...
FDA Approves Pediatric Use Of Chemical Poisoning Treatment
The U.S. Food and Drug Administration has approved the pediatric use of Protopam Chloride (pralidoxime chloride), a drug used to treat poisoning by organophosphate pesticides and chemicals (e.g., nerve agents). The drug is approved to be administered either by intravenous (IV) or intramuscular (IM) injections...
Calif. Regulators Seek $9.9 Bn Fine From Insurer; Few Iowans Sign Up For High Risk Pool; N.D. Court Rejects Ballot Measure On Drug Store Ownership
Reuters: "California regulators are seeking fines of up to $9.9 billion from a unit of health insurer UnitedHealth Group Inc, citing mismanaged medical claims, failure to pay doctors and other lapses. The California Department of Insurance alleges that PacifiCare violated state law nearly a million times from 2006 to 2008 after it was purchased by UnitedHealth, the largest U.S...
Study Of Investigational Agent Abiraterone Acetate For Metastatic Advanced Prostate Cancer Unblinded After Meeting Pre-Determined Criteria
Ortho Biotech Oncology Research & Development, a unit of Cougar Biotechnology, Inc...
Tengion Adds The Johns Hopkins Hospital As An Additional Clinical Trial Site For Its Phase I Neo-Urinary Conduit™ Clinical Trial
Tengion, Inc., a leader in regenerative medicine, announced it has added The Johns Hopkins Hospital in Baltimore, Maryland as a second clinical trial site for its Phase I clinical trial of the Company's lead product candidate, the Tengion Neo-Urinary Conduit™, in bladder cancer patients requiring bladder removal...
FDA Grants Fast Track Status To Tideglusib (ZentylorTM) For Progressive Supranuclear Palsy
Noscira, a Grupo Zeltia (ZEL.MC) subsidiary specialized in research and development of drugs to treat neurodegenerative diseases, has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track status to its neuroprotector drug Tideglusib (ZentylorTM) to treat Progressive Supranuclear Palsy (PSP), a fast-advancing fatal degenerative brain disorder...
Key Pharmacogenomics Resource Expanded By NIH
To help advance research on how genes affect responses to medicines, the National Institutes of Health is spending $15 million over five years to expand a key resource, the Pharmacogenomics Knowledge Base (PharmGKB). The goal of pharmacogenomics is to use information about a patient's genetic make-up to optimize his or her medical treatment. As the field has grown, so has PharmGKB...
Federal Appeals Court Declines To Reconsider 'Pay-For-Delay' On Generic Drugs
A federal appeals court on Tuesday said it will not revisit its decision to uphold settlements that allow pharmaceutical companies to pay competitors to keep generic versions of their drugs off the market, The Wall Street Journal reports. "In April, the U.S...
MAP Pharmaceuticals Announces All Non-Asthmatic Patients Complete Treatment In Open-Label Trial And Completion Of Treatment In QT Trial For LEVADEXtm
MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) announced that all non-asthmatic patients and a subset of asthmatic patients have completed 12 months of treatment in the open-label safety trial of LEVADEX™. In addition, the Company has completed patient treatment in a thorough QT trial, the last trial necessary to support a New Drug Application (NDA) for LEVADEX...
Enobia Provides Update On Progress With ENB-0040, A Bone-Targeted Enzyme Replacement Therapy For Hypophosphatasia
Enobia Pharma provided an update on key developments in its comprehensive effort to develop ENB-0040 (asfotase alfa), an experimental bone-targeted enzyme replacement therapy, for the treatment of hypophosphatasia (HPP). Hypophosphatasia is a rare, inherited, and sometimes fatal metabolic bone disease that affects individuals of all ages...
Cylene To Report Recent Advances With First-in-Class CK2 Inhibitor, CX-4945, At International CK2 Conference
Cylene Pharmaceuticals, Inc. will report recent developments with its first-in-class, oral CK2 inhibitor CX-4945, at the 6th International Conference on Protein Kinase CK2, to be held on September 7-10 in Cologne, Germany, the company announced. CX-4945 is potentially a dynamic anticancer therapeutic, as both a stand-alone drug and for use in combination therapies...
Ariana(R) Pharma Collaborates With The FDA To Facilitate Signature Validation For The Development Of Biomarkers
Ariana Pharma, a leader in decision support tools and services to accelerate the development and optimal use of drugs and biomarker discovery, announces that it has started a collaboration with the US Food and Drug Administration (FDA)...
UC San Diego To Lead New Pharmacogenomics Project
An international team, led by University of California, San Diego School of Medicine researchers, has been awarded a $6.5 million grant from the National Institutes of Health (NIH) to study the pharmacogenomics of a key mood-stabilizing drug used to treat bipolar disorder...
Cuts To Public Spending On Research Will Jeopardise Funding For Medical Research From Private And Charitable Sources, UK
The Academy of Medical Sciences has warned that the UK's competitive advantage in medical science is reliant on a Government commitment to maintaining a thriving publicly funded research base. Any cuts risk damaging the UK's rich landscape of medical research funders and would jeopardise the private and charitable funding leveraged by public spending...
Court Denies Sandoz/Momenta's Summary Judgment Of Invalidity In Copaxone(R) Litigation
Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA) announced today that the U.S. District Court for the Southern District of New York has denied a motion for summary judgment filed by Sandoz Inc./Momenta Pharmaceuticals, Inc., that the patents at issue are invalid for indefiniteness. The court has not yet set a trial date...
The Benefits Of Hormone Replacement Therapy Overstated And Harms Downplayed By Ghostwritten Articles
The first academic analysis of the 1500 documents unsealed in recent litigation against the pharmaceutical giant Wyeth (now part of Pfizer) reveals unprecedented insights into how pharmaceutical companies use ghostwriters to insert marketing messages into articles published in medical journals. Dr...
4th Annual Biomarker Discovery And Development Conference, San Francisco, CA Oct. 20-22, 2010
The 4th Annual Biomarker Discovery and Development Conference features presentations of novel technologies to discover biomarkers, how they are utilized to streamline the development process by reducing time and costs and minimize drug attrition associated with safety concerns, and highlight their utility in clinical trials and as companion diagnostics in the clinics...
Children's Hospital Boston And Particle Sciences Cooperate On Translational Medicine Efforts
Particle Sciences Inc. (PSI), a leading pharmaceutical Contract Research Organization (CRO), has been engaged by Children's Hospital Boston to help advance early stage molecules and drug innovations into new therapeutic products for patient care...
TenX Biopharma Reinitiates Enrollment In Pivotal Phase III, CTCL Trial
TenX Biopharma, Inc. announced that it has re-initiated enrollment in the pivotal Phase III clinical trial assessing zanolimumab treatment for cutaneous T-cell lymphoma (CTCL) patients. The trial enrollment was suspended in October 2008 while Genmab (CO:GEN) was seeking a out-license agreement to further develop the compound...
To Reach, Perchance To Kill The Cancer: A Soliloquy From Epeius Nanotechnologies Opposes That 'Sea Of Troubles'
Epeius Biotechnologies Corporation, a leader in the emerging field of targeted genetic medicine, reports the publication of a landmark paper in clinical oncology. Following up on its advanced U.S...


7r5wk2sayt

Powered by FirstRSS Plugin